Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.

× No keyword cloud information.

36 in total

1. Activity of pyrazinamide in the guinea pig model of tuberculosis.

Authors: Denis A Mitchison
Journal: Antimicrob Agents Chemother Date: 2010-12 Impact factor: 5.191

Review 2. Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors: Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal: Expert Opin Pharmacother Date: 2009-02 Impact factor: 3.889

3. Ultra-short-course chemotherapy for spinal tuberculosis: five years of observation.

Authors: Zili Wang; Jiandang Shi; Guangqi Geng; Hongyan Qiu
Journal: Eur Spine J Date: 2012-10-11 Impact factor: 3.134

Review 4. Molecular epidemiology of tuberculosis: current insights.

Authors: Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal: Clin Microbiol Rev Date: 2006-10 Impact factor: 26.132

Review 5. New trends in the chemotherapy of tuberculosis--current aspects.

Authors: M Zierski
Journal: Pneumonologie Date: 1974-06-14

6. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Authors: Susan E Dorman; Radojka M Savic; Stefan Goldberg; Jason E Stout; Neil Schluger; Grace Muzanyi; John L Johnson; Payam Nahid; Emily J Hecker; Charles M Heilig; Lorna Bozeman; Pei-Jean I Feng; Ruth N Moro; William MacKenzie; Kelly E Dooley; Eric L Nuermberger; Andrew Vernon; Marc Weiner
Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405

7. Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors: John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal: Curr Top Microbiol Immunol Date: 2013 Impact factor: 4.291

8. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.

Authors: Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques Grosset
Journal: Antimicrob Agents Chemother Date: 2009-07-20 Impact factor: 5.191

9. Medical management of genitourinary tuberculosis.

Authors: Tamilarasu Kadhiravan; Surendra K Sharma
Journal: Indian J Urol Date: 2008-07

Review 10. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors: Dick Menzies; Andrea Benedetti; Anita Paydar; Ian Martin; Sarah Royce; Madhukar Pai; Andrew Vernon; Christian Lienhardt; William Burman
Journal: PLoS Med Date: 2009-09-15 Impact factor: 11.069